Coronavirus Vaccine
/ Korea Research Institute of Chemical Technology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 26, 2024
Coronavirus Nucleocapsid-based Vaccine Provides Partial Protection against Hetero-species Coronavirus in Murine Models.
(PubMed, Antiviral Res)
- "However, in K18-hACE transgenic mice, the vaccine showed limited protection. Collectively, our findings suggest that coronavirus N can be an effective vaccine antigen against homologous viruses, but its efficacy may vary across different coronaviruses, highlighting the need for further research on pan-coronavirus vaccines using conserved antigens."
Journal • Preclinical • Infectious Disease • Inflammation • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
1 to 1
Of
1
Go to page
1